Discover how QFR transforms diagnostic tools for Epicardial and Microvascular Disease in the Cath Lab

Reading time: 3 mins
Written on: April 25, 2024
– Learn how the newest QFR technology enables coronary physiology analysis in under 30 seconds. – Understand the role of QFR-IMR as a diagnostic tool for coronary microvascular dysfunction assessment. – Learn how QFR paves the way for new horizons in treatment options.
– Learn how the newest QFR technology enables coronary physiology analysis in under 30 seconds. – Understand the role of QFR-IMR as a diagnostic tool for coronary microvascular dysfunction assessment. – Learn how QFR paves the way for new horizons in treatment options. QFR: the next-generation diagnostic tool for Epicardial and Microvascular Disease in the Cath Lab 📅 Wednesday, May 15th 🕞 16:30 to 17:15 (CEST) 📍 Room 253 Prof. Gianluca Campo and Prof. Hector Manuel Garcia-Garcia MD PhD will moderate four insightful presentations by esteemed speakers: Dr. Salvatore Brugaletta, Dr. Joanna Wykrzykowska, Dr. Javier Escaned, and Dr. Victor Tadros.They will share their expertise and insights on Medis QFR® 3.0 and QFR-IMR parameters. Join us for an informative session in collaboration with GE HealthCare and BIOTRONIK. We are looking forward to seeing you all there!

Share this article on:

Latest news

GE HealthCare and Medis Medical Imaging Announce Collaboration focused on Non-Invasive Coronary Assessments to Help Advance Precision Care in Treatment of Coronary Artery Disease 

Today, GE HealthCare (Nasdaq: GEHC), a leading global medical technology, pharmaceutical diagnostics and digital solutions innovator, and Medis Medical Imaging, a leading cardiac imaging software company, announced their collaboration aimed at helping advance precision care in the diagnosis and treatment

Read this article

Do you want to stay up-to-date on our latest news? Join our newsletter.

Would you like to get our latest news, insights, blogs or tips & tricks directly into your mailbox? Please sign up for our newsletter